David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.52B |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$620M |
| 3 |
Pfizer
PFE
|
+$449M |
| 4 |
American International
AIG
|
+$403M |
| 5 |
Walmart Inc
WMT
|
+$392M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.87% |
| 2 | Financials | 8.04% |
| 3 | Healthcare | 7.54% |
| 4 | Consumer Discretionary | 7.27% |
| 5 | Energy | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
AutoZone
AZO
$48.3B
| $36.3M | 0.07% |
+85,770
| New | +$35M |
|
|
MDVN
302
DELISTED
MEDIVATION, INC.
MDVN
| $36.3M | 0.07% |
+1,476,324
| New | +$37.2M |
|
303
Henry Schein
HSIC
$9.86B
| $36.3M | 0.07% |
+966,753
| New | +$35.4M |
|
304
Primerica
PRI
$9.1B
| $36.3M | 0.07% |
+969,004
| New | +$33.4M |
|
|
OCR.PRB
305
DELISTED
OMNICARE CAP TR II SER B 4% TR PFD INCM EQTY REDM SEC PIERS
OCR.PRB
| – | – |
0
| – | – |
|
306
CALL
Booking.com
BKNG
$158B
| $36.2M | 0.07% |
+1,095,000
| New | +$33.5M |
|
307
Baidu
BIDU
$31.6B
| $36.2M | 0.07% |
+382,673
| New | +$35.3M |
|
308
CALL
Seagate
STX
$193B
| $36.2M | 0.07% |
+806,700
| New | +$32.5M |
|
309
PUT
ExxonMobil
XOM
$679B
| $36M | 0.07% |
+398,300
| New | +$35.8M |
|
|
AGN
310
DELISTED
Allergan Inc
AGN
| $36M | 0.07% |
+427,159
| New | +$44.3M |
|
311
F5
FFIV
$21.8B
| $35.9M | 0.07% |
+521,214
| New | +$40.1M |
|
312
PUT
Biogen
BIIB
$32B
| $35.9M | 0.07% |
+166,600
| New | +$35.6M |
|
|
VMW
313
PUT
DELISTED
VMware, Inc
VMW
| $35.7M | 0.07% |
+532,800
| New | +$39M |
|
314
PUT
Tapestry
TPR
$26B
| $35.5M | 0.07% |
+622,000
| New | +$35M |
|
|
PARA
315
DELISTED
Paramount Global Class B
PARA
| $35.5M | 0.07% |
+726,180
| New | +$33.2M |
|
316
PUT
Marathon Petroleum
MPC
$101B
| $35.2M | 0.07% |
+992,000
| New | +$39.6M |
|
317
Adeia
ADEA
$2.89B
| $35.2M | 0.07% |
+6,401,611
| New | +$34.1M |
|
318
Harley-Davidson
HOG
$2.93B
| $35.2M | 0.07% |
+641,332
| New | +$34.7M |
|
|
VPHM
319
DELISTED
VIROPHARMA INC
VPHM
| $35.1M | 0.07% |
+1,224,515
| New | +$32.3M |
|
320
CALL
Bank of America
BAC
$431B
| $34.8M | 0.07% |
+2,707,900
| New | +$34.5M |
|
321
Nucor
NUE
$55.3B
| $34.7M | 0.07% |
+800,000
| New | +$35.5M |
|
322
CALL
Coca-Cola
KO
$392B
| $34.6M | 0.07% |
+863,300
| New | +$35.7M |
|
323
PUT
Toyota
TM
$234B
| $34.6M | 0.07% |
+286,500
| New | +$33.5M |
|
|
MCRS
324
DELISTED
MICROS SYSTEMS INC
MCRS
| $34.5M | 0.06% |
+800,000
| New | +$34.6M |
|
325
PUT
Costco
COST
$420B
| $34.4M | 0.06% |
+310,800
| New | +$34M |
|
Similar funds
David Shaw's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for David Shaw, which disclosed 3,939 positions worth $53.2B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Apple: 99,088,976 shares worth $1.4B.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, followed by Financials and Healthcare.
- David Shaw's largest Q2 2013 buy was Apple: 99,088,976 shares worth $1.4B.
- David Shaw's ten largest holdings make up 15% of its $53.2B portfolio in Q2 2013.
- David Shaw disclosed 3,939 positions in Q2 2013, its first 13F filing on record.
Based on D.E. Shaw & Co's 13F filing for Q2 2013, filed 14 Aug 2013.